Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

Erstveröffentlichung
2021
Authors
Byrd, John C.
Hillmen, Peter
Ghia, Paolo
Kater, Arnon P.
Chanan-Khan, Asher
et al.
Wissenschaftlicher Artikel


Published in
Journal of Clinical Oncology ; 39 (2021), 31. - S. 3441-3452. - ISSN 0732-183X. - eISSN 1527-7755
Link to publication
https://dx.doi.org/10.1200/JCO.21.01210
Institutions
UKU. Klinik für Innere Medizin III
Subject headings
[Free subject headings]: TYROSINE KINASE INHIBITOR | ATRIAL-FIBRILLATION | RISK | MANAGEMENT | ACP-196 | THERAPY | CLL | BTK
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record